Skip to main content

Advertisement

Log in

Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The use of complementary and alternative medicine (CAM) in cancer has been increasing. The therapeutic modalities which originated from India, viz., Ayurveda and Siddha, have phytotherapy as their fundamental basis and, therefore, produce few side effects. They are among the most ancient medicinal systems and are still being practiced in India and elsewhere, to cure cancer and other diseases. Many Siddha practitioners in the southern parts of India prescribe rasagenthi lehyam (RL) as a drug for cancer. RL contains 38 different botanicals, many of which have been shown to possess therapeutic efficacy, and 8 inorganic compounds, all prepared into a paste in a palm sugar and hen’s egg base. The efficacy of RL in killing prostate cancer cells in vitro was investigated in this study to determine whether RL could be recommended as a CAM for prostate cancer.

Methods

In order to scientifically validate the anticancer activity of RL on prostate cancer, a methanolic extract of RL was serially extracted with four organic solvents, and the extracts were tested for clonogenic inhibition and induction of apoptosis in PC-3 prostate cancer cells, with and without irradiation. n-Hexane, ethyl acetate and chloroform extracts of RL effectively killed PC-3 cells.

Results

The IC50 values of n-hexane, ethyl acetate and chloroform extracts of RL were 3.84 μg/ml, 3.68 μg/ml and 75 ng/ml, respectively. All three extracts induced apoptosis in PC-3 cells. Further, all the three extracts when combined with radiation, caused enhanced effect on killing of PC-3 cells. Among the three extracts, the chloroform extract showed the most significant radiation-sensitizing effect.

Conclusion

RL, either in its original formulation prepared under strict quality control or its chloroform extract, could potentially be an alternative medicine for prostate cancer, and also a sensitizing agent in the context of radiation therapy for prostate cancer, as a complementary medicine. A more directed study could lead to the identification of the active principle(s) in the chloroform extract of RL for use in prostate cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3A, B
Fig. 4A–D
Fig. 5

Similar content being viewed by others

References

  1. Acuna UM, Atha DE, Ma J, Nee MH, Kennelly EJ (2002) Antioxidant capacities of ten edible North American plants. Phytother Res 16:63–65

    Article  PubMed  Google Scholar 

  2. Aruna K, Sivaramakrishnan VM (1992) Anticarcinogenic effects of some Indian plant products. Food Chem Toxicol 30:953–956

    Article  CAS  PubMed  Google Scholar 

  3. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295–300

    CAS  PubMed  Google Scholar 

  4. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360:103–106

    Article  CAS  PubMed  Google Scholar 

  5. Chen X, Hasuma T, Yano Y, Yoshimata T, Morishima Y, Wang Y, Otani S (1997) Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 17:2555–2564

    CAS  PubMed  Google Scholar 

  6. Chendil D, Oakes R, Alcock RA, Patel N, Mayhew C, Mohiuddin M, Gallicchio VS, Ahmed MM (2000) Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer 89:1893–1900

    Article  CAS  PubMed  Google Scholar 

  7. Chendil D, Das A, Dey S, Mohiuddin M, Ahmed MM (2002) Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Cancer Biol Ther 1:152–160

    CAS  PubMed  Google Scholar 

  8. Chidambara Murthy KN, Singh RP, Jayaprakasha GK (2002) Antioxidant activities of grape (Vitis vinifera) pomace extracts. J Agric Food Chem 50:5909–5914

    Article  PubMed  Google Scholar 

  9. Dabancens A, Zipper J, Guerrero A (1994) Quinacrine and copper, compounds with anticonceptive and antineoplastic activity. Contraception 50:243–251

    CAS  PubMed  Google Scholar 

  10. Darzynkiewicz Z, Traganos F, Wu JM, Chen S (2000) Chinese herbal mixture PC SPES in treatment of prostate cancer (review). Int J Oncol 17:729–736

    CAS  PubMed  Google Scholar 

  11. de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schroder FH (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97:237–244

    Article  PubMed  Google Scholar 

  12. Devi PU, Kamath R, Rao BS (2000) Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J Exp Biol 38:432–437

    CAS  PubMed  Google Scholar 

  13. Dorai T, Gehani N, Katz A (2000) Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4:1–6

    CAS  PubMed  Google Scholar 

  14. Flynn DL, Rafferty MF, Boctor AM (1986) Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22:357–360

    CAS  PubMed  Google Scholar 

  15. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT (1994) The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54:6167–6175

    CAS  PubMed  Google Scholar 

  16. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7–33

    CAS  PubMed  Google Scholar 

  17. Hussain SP, Rao AR (1991) Chemopreventive action of mace (Myristica fragrans, Houtt) on methylcholanthrene-induced carcinogenesis in the uterine cervix in mice. Cancer Lett 56:231–234

    CAS  PubMed  Google Scholar 

  18. Ibrahim AS, Latif AH (2002) Adult lead poisoning from a herbal medicine. Saudi Med J 23:591–593

    PubMed  Google Scholar 

  19. Inayat MS, Chendil D, Mohiuddin M, Elford HL, Gallicchio VS, Ahmed MM (2002) Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. Cancer Biol Ther 1:539–545

    PubMed  Google Scholar 

  20. Jeswal P (1998) Antidotal effect of grape juice (Vitis vinifera) on ochratoxin A caused hepatorenal carcinogenesis in mice (Mus musculus). Cytobios 93:123–128

    CAS  PubMed  Google Scholar 

  21. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO (1997) Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 277:467–471

    Article  CAS  PubMed  Google Scholar 

  22. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R (2002) Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology 59:272–276

    PubMed  Google Scholar 

  23. Kao GD, Devine P (2000) Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88:615–619

    CAS  PubMed  Google Scholar 

  24. Kasprzak KS, Diwan BA, Rice JM (1994) Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology 90:129–140

    Article  CAS  PubMed  Google Scholar 

  25. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 40:387–391

    Google Scholar 

  26. Kumar MH, Gupta YK (2002) Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism in enhancing cognition. Phytomedicine 9:302–311

    CAS  PubMed  Google Scholar 

  27. Lee SE, Ju EM, Kim JH (2001) Free radical scavenging and antioxidant enzyme fortifying activities of extracts from Smilax china root. Exp Mol Med 33:263–268

    CAS  PubMed  Google Scholar 

  28. Mathews V, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A (2002) Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. Am J Hematol 70:292–299

    Article  CAS  PubMed  Google Scholar 

  29. Mazumdar UK, Gupta M, Maiti S, Mukherjee D (1997) Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Indian J Exp Biol 35:473–477

    CAS  PubMed  Google Scholar 

  30. Okita K, Li Q, Murakamio T, Takahashi M (1993) Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev 2:169–175

    CAS  PubMed  Google Scholar 

  31. Parcell S (2002) Sulfur in human nutrition and applications in medicine. Altern Med Rev 7:22–44

    PubMed  Google Scholar 

  32. Park HJ, Jung WT, Basnet P, Kadota S, Namba T (1996) Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J Nat Prod 59:1128–1130

    Article  CAS  PubMed  Google Scholar 

  33. Park KK, Chun KS, Lee JM, Lee SS, Surh YJ (1998) Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129:139–144

    Article  CAS  PubMed  Google Scholar 

  34. Park S, Lee DK, Yang CH (1998) Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett 127:23–28

    Article  CAS  PubMed  Google Scholar 

  35. Paul B, Masih I, Deopujari J, Charpentier C (1999) Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol 68:71–76

    Article  CAS  PubMed  Google Scholar 

  36. Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP, Chapuis JC (1996) Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol 53:57–63

    Article  CAS  PubMed  Google Scholar 

  37. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS (2001) Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 19:1830–1838

    CAS  PubMed  Google Scholar 

  38. Premalatha B (2000) Semecarpus anacardium Linn. nuts—a boon in alternative medicine. Indian J Exp Biol 38:1177–1182

    CAS  PubMed  Google Scholar 

  39. Premalatha B, Sachdanandam P (2000) Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)-induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes. Pharmacol Res 42:161–166

    Article  CAS  PubMed  Google Scholar 

  40. Saleem A, Husheem M, Harkonen P, Pihlaja K (2002) Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol 81:327–336

    Article  CAS  PubMed  Google Scholar 

  41. Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR (1992) Antitumour principles from Nigella sativa seeds. Cancer Lett 63:41–46

    CAS  PubMed  Google Scholar 

  42. See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ (2002) Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J Urol 168:429–435

    PubMed  Google Scholar 

  43. Shaw D, Leon C, Kolev S, Murray V (1997) Traditional remedies and food supplements. A 5-year toxicological study (1991–1995). Drug Saf 17:342–356

    Google Scholar 

  44. Shim MJ, Kim HJ, Yang SJ, Lee IS, Choi HI, Kim T (2002) Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J Biochem Mol Biol 35:377–383

    CAS  PubMed  Google Scholar 

  45. Shukla PK, Khanna VK, Ali MM, Maurya RR, Handa SS, Srimal RC (2002) Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytother Res 16:256–260

    Article  PubMed  Google Scholar 

  46. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18:3595–3603

    CAS  PubMed  Google Scholar 

  47. Smith M, Mills EJ (2001) Select complementary/alternative therapies for prostate cancer: the benefits and risks. Cancer Pract 9:253–255

    Article  PubMed  Google Scholar 

  48. Soleas GJ, Diamandis EP, Goldberg DM (1997) Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30:91–113

    Article  CAS  PubMed  Google Scholar 

  49. Srivastava KC (1988) Extract of a spice—omum (Trachyspermum ammi)—shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Prostaglandins Leukot Essent Fatty Acids 33:1–6

    CAS  PubMed  Google Scholar 

  50. Sujatha V, Sachdanandam P (2002) Recuperative effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother Res 16 [Suppl 1]:S14–18

    Google Scholar 

  51. Surh YJ (2002) Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40:1091–1097

    Article  CAS  PubMed  Google Scholar 

  52. Surh YJ, Lee E, Lee JM (1998) Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutat Res 402:259–267

    Article  CAS  PubMed  Google Scholar 

  53. Vickers A, Zollman C (1999) ABC of complementary medicine: herbal medicine. BMJ 319:1050–1053

    CAS  PubMed  Google Scholar 

  54. Waffo-Teguo P, Hawthorne ME, Cuendet M, Merillon JM, Kinghorn AD, Pezzuto JM, Mehta RG (2001) Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer 40:173–179

    Article  CAS  PubMed  Google Scholar 

  55. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW (2002) Attitudes and use of complementary medicine in men with prostate cancer. J Urol 168:2505–2509

    PubMed  Google Scholar 

  56. Woynarowski JM, Napier C, Koester SK, Chen SF, Troyer D, Chapman W, MacDonald JR (1997) Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114). Biochem Pharmacol 54:1181–1193

    CAS  PubMed  Google Scholar 

  57. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M (1994) The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 54:448–454

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Damodaran Chendil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ranga, R.S., Girija, R., Nur-e-alam, M. et al. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer Chemother Pharmacol 54, 7–15 (2004). https://doi.org/10.1007/s00280-004-0770-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-004-0770-9

Keywords

Navigation